Skip Navigation



JAC Advance Access published online on November 11, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki411
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
57/1/4    most recent
dki411v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Grabar, S.
Right arrow Articles by Costagliola, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grabar, S.
Right arrow Articles by Costagliola, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Leading article

HIV infection in older patients in the HAART era

Sophie Grabar 1*, Laurence Weiss 2, and Dominique Costagliola 3

1 Service de Biostatistique et Informatique Médicale, Université Paris-Descartes, Faculté de Médecine, Hôpital Cochin, Paris, France; Unité 720 INSERM et Université Pierre et Marie Curie, Paris, France
2 Department of Clinical Immunology, Université Paris-Descartes, Faculté de Médecine, Hôpital Européen Georges Pompidou, Paris, France
3 Unité 720 INSERM et Université Pierre et Marie Curie, Paris, France

* To whom correspondence should be addressed.
Sophie Grabar, E-mail: grabar{at}cochin.univ-paris5.fr


  Abstract

An increasing number of patients over 50 years of age are now living with HIV, owing to highly active antiretroviral therapy (HAART) that prolongs survival on the one hand and to late diagnosis of patients living with occult HIV infection on the other hand. Most studies have shown that compared with younger patients, patients over 50 generally have a slower immunological response to HAART and experience more rapid clinical progression, despite a better virological response. Low thymic output probably plays a role in the poorer CD4 cell response in patients initiating HAART over 50 years. Management of HIV infection in older patients is particularly complex, mainly because they are more likely to have co-morbidities necessitating specific medications that may interact with antiretroviral drugs. More controlled studies of HAART efficacy and tolerability in such patients are needed to establish specific management guidelines. Information campaigns targeting older patients and their doctors are also needed to ensure timely diagnosis of HIV infection and antiretroviral treatment initiation.

Keywords: antiretroviral treatment; elderly; HIV/AIDS.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 West J Nurs ResHome page
C. L. Coleman and K. Ball
Predictors of Self-Efficacy to Use Condoms Among Seropositive Middle-Aged African American Men
West J Nurs Res, November 1, 2009; 31(7): 889 - 904.
[Abstract] [PDF]

Home page
 BMJHome page
K. A Gebo
HIV infection in older people
BMJ, June 15, 2009; 338(jun15_2): b1460 - b1460.
[Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
M. Amano, Y. Koh, D. Das, J. Li, S. Leschenko, Y.-F. Wang, P. I. Boross, I. T. Weber, A. K. Ghosh, and H. Mitsuya
A Novel Bis-Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI), GRL-98065, Is Potent against Multiple-PI-Resistant Human Immunodeficiency Virus In Vitro
Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2143 - 2155.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
C. Torti, G. Lapadula, P. Barreiro, V. Soriano, S. Mandalia, A. De Silvestri, F. Suter, F. Maggiolo, A. Antinori, F. Antonucci, et al.
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load
J. Antimicrob. Chemother., June 1, 2007; 59(6): 1141 - 1147.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.